At what ages should the Ages and Stages Questionnaire (ASQ) be performed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

ASQ Screening Ages

The Ages and Stages Questionnaire (ASQ) should be performed at 9,18, and 30 months of age (or 24 months as an alternative to 30 months), combined with developmental surveillance at all well-child visits. 1

Recommended Screening Schedule

The American Academy of Pediatrics guideline explicitly recommends:

  • 9 months of age - First formal ASQ screening
  • 18 months of age - Second formal ASQ screening
  • 30 months of age (or 24 months as alternative) - Third formal ASQ screening

This recommendation applies to standardized developmental screening tools in general, with the ASQ specifically mentioned as one of the preferred parent-completed instruments 1.

Rationale for These Specific Ages

These three time points are strategically chosen because:

  • Early detection is critical: Up to 50% of children with developmental delays are missed before kindergarten entry, even though most show delays by 2 years of age 1
  • Clinical judgment alone is inadequate: Physician impression alone would miss 45% of children eligible for early intervention 1
  • Surveillance alone has poor sensitivity: Checklists and clinical observation without standardized tools fail to detect many delays 1

Important Implementation Details

The ASQ-3 demonstrates strong psychometric properties:

  • Overall sensitivity: 85%
  • Overall specificity: 86%
  • Strong test-retest reliability (r = 0.94)
  • Feasible in busy clinical settings without impeding office flow 1

Key caveat: While these are the recommended ages for formal screening, developmental surveillance (informal monitoring through history and observation) should occur at every well-child visit, not just at screening ages 1.

Practical Considerations

The ASQ is specifically recommended as a parent-completed tool rather than a directly administered instrument, which makes it more practical for busy primary care settings 1. The 30-month visit faces reimbursement challenges in some settings, which is why 24 months is offered as an acceptable alternative 1.

References

Guideline

screening for developmental delay.

American family physician, 2011

Related Questions

Does the Ages and Stages Questionnaire (ASQ) include children up to 4 years old?
A 10‑day postpartum woman presents with dysuria and a urine culture growing mixed microbiota >100,000 CFU/mL; how should this be managed?
What is the appropriate 10‑day antibiotic regimen for a patient undergoing ENT follow‑up after image‑guided fine‑needle aspiration/biopsy, assuming no documented β‑lactam allergy?
In a 10‑month‑old infant with a slightly indented coronal suture, normal fontanelles, and appropriate head growth, what is the appropriate next step in management?
What is the minimum recommended duration of antimicrobial therapy for a deep puncture wound?
What are the common and serious side effects of paroxetine?
Which of the following statements regarding a black widow spider bite is incorrect? A) The spider is over 4 cm long, black, and has an orange spot on its abdomen. B) It causes transient pain and local necrosis, and the patient may initially ignore it. C) Its toxin is neurotoxic; it can cause severe abdominal muscle spasms and mimic an acute abdomen or peritonitis. D) Symptoms subside within 48 hours. E) Hospitalization is not required.
In a patient with hyponatremia (serum sodium 133 mEq/L) taking lisinopril 40 mg daily, should I increase dietary sodium intake or adjust the lisinopril therapy?
What heparin (unfractionated heparin or low‑molecular‑weight heparin) is preferred for patients with chronic kidney disease and how should the dose be adjusted based on estimated glomerular filtration rate?
What is the optimal medication regimen for a 12‑year‑old boy with Disruptive Mood Dysregulation Disorder who continues to have emotional dysregulation?
What is the most likely diagnosis and appropriate workup and management for a 16-year-old female with microcytic anemia (Hb 9.1 g/dL, Hct 30.1 %, MCV 66.2 fL, RDW 17.6 %) and severe obesity (weight 136 kg)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.